Discontinuation report AVANDIA
| Report ID | 113314 |
| Drug Identification Number | 02241113 |
| Brand name | AVANDIA |
| Common or Proper name | rosiglitazone (as rosiglitazone maleate) tablets |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ROSIGLITAZONE |
| Strength(s) | 4MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100's |
| ATC code | A10BG |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-12-01 |
| Remaining supply date | 2021-04-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-12-11 | French | Compare |
| v5 | 2020-12-11 | English | Compare |
| v4 | 2020-11-27 | French | Compare |
| v3 | 2020-11-27 | English | Compare |
| v2 | 2020-04-27 | French | Compare |
| v1 | 2020-04-27 | English | Compare |
Showing 1 to 6 of 6